May 2019 News & Views: Survey Identifies Barriers and Solutions to Biosimilar Adoption; In Memoriam: Past President Cathy Carroll; CEO Blog: PAs Play Key Role in Appropriate Medication Use; PGY1 Residents First to Rotate at AMCP/Foundation Headquarters
The Academy of Managed Care Pharmacy (AMCP) thanks the Department of Health and Human Services Office of Inspector General (HHS-OIG) for the opportunity to provide comments in response to the proposed rule titled “Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of a New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees [OIG-0936-P]” published in the Federal Register on February 6, 2019.
Press Release: From News&Views April 2019: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies.
AMCP writes to request your veto on House Bill 435 which implements an exception process for coverage of a drug removed from a formulary at the previous cost sharing level. Imposing government mandated restrictions on formularies as outlined in the bill could have the unintended consequence of raising the overall cost of health care coverage for patients.
From April 2019 News & Views: AMCP and the AMCP Foundation last month recognized a group of thought leaders for their significant contributions to the profession of managed care pharmacy.
From April 2019 News & Views: Four student pharmacists from the University of Washington School of Pharmacy took top honors in the Academy of Managed Care Pharmacy (AMCP) Foundation 19th National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition.